Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eileen Poon

Showing results (11-20 of 29) with videos related to

Pageof 3
Sort By:
Haematologica|November 5, 2020
Phase I study of selinexor in combination with dexamethasone, ifosfamide, carboplatin, etoposide chemotherapy in patients with relapsed or refractory peripheral T-cell or natural-killer/T-cell lymphomaTiffany Tang, Peter Martin, Nagavalli Somasundaram, et al.
Scientific Reports|October 2, 2020
Clinical features and survival outcomes of ocular melanoma in a multi-ethnic Asian cohortLaura Ling Ying Tan, Jiancheng Hong, Wei Lin Goh, et al.
BMC Cancer|May 18, 2021
Treatment patterns and outcomes of older patients with mantle cell lymphoma in an Asian populationXinyi Yang, Lay Poh Khoo, Esther Wei Yin Chang, et al.
Leukemia & Lymphoma|February 21, 2022
Burkitt lymphoma - no impact of HIV status on outcomes with rituximab-based chemoimmunotherapyJing Yuan Tan, Tian Yu Qiu, Jianbang Chiang, et al.
Journal of Hematology|September 16, 2021
Treatment Outcomes and Survival Patterns of Asian Patients With Relapsed/Refractory Mantle Cell LymphomaJing Yuan Tan, Tian Yu Qiu, Jianbang Chiang, et al.
Annals of the Academy of Medicine, Singapore|February 4, 2010
A unique pair of monozygotic twins with concordant clear cell renal cell carcinoma: a case reportMin Han Tan, Jasmine Yang, Hwei Ling Tan, et al.
European Urology|July 15, 2014
A multigene assay identifying distinct prognostic subtypes of clear cell renal cell carcinoma with differential response to tyrosine kinase inhibitionYukti Choudhury, Xiaona Wei, Ying-Hsia Chu, et al.
Leukemia & Lymphoma|June 10, 2022
Clinicopathological factors affecting prognosis in marginal zone lymphoma in Asian patients: a cohort studyYao Hao Teo, Yao Neng Teo, Lay Poh Khoo, et al.
The Journal of Trauma and Acute Care Surgery|June 14, 2023
Longitudinal study evaluating post-ICU syndrome differences between acute care surgery and trauma SICU survivorsSamantha F Bottom-Tanzer, Janelle O Poyant, Maria T Louzada, et al.
Pharmacotherapy|February 6, 2021
Clinical and economic evaluation of a surveillance protocol to manage hepatitis B virus (HBV) reactivation among lymphoma patients with resolved HBV infection receiving rituximabChia Jie Tan, Rajneesh Kumar, Narendran Koomanan, et al.
Pageof 3

Showing results (11-20 of 29) with videos related to

Sort By:
Pageof 3
Haematologica|November 5, 2020
Phase I study of selinexor in combination with dexamethasone, ifosfamide, carboplatin, etoposide chemotherapy in patients with relapsed or refractory peripheral T-cell or natural-killer/T-cell lymphomaTiffany Tang, Peter Martin, Nagavalli Somasundaram, et al.
Scientific Reports|October 2, 2020
Clinical features and survival outcomes of ocular melanoma in a multi-ethnic Asian cohortLaura Ling Ying Tan, Jiancheng Hong, Wei Lin Goh, et al.
BMC Cancer|May 18, 2021
Treatment patterns and outcomes of older patients with mantle cell lymphoma in an Asian populationXinyi Yang, Lay Poh Khoo, Esther Wei Yin Chang, et al.
Leukemia & Lymphoma|February 21, 2022
Burkitt lymphoma - no impact of HIV status on outcomes with rituximab-based chemoimmunotherapyJing Yuan Tan, Tian Yu Qiu, Jianbang Chiang, et al.
Journal of Hematology|September 16, 2021
Treatment Outcomes and Survival Patterns of Asian Patients With Relapsed/Refractory Mantle Cell LymphomaJing Yuan Tan, Tian Yu Qiu, Jianbang Chiang, et al.
Annals of the Academy of Medicine, Singapore|February 4, 2010
A unique pair of monozygotic twins with concordant clear cell renal cell carcinoma: a case reportMin Han Tan, Jasmine Yang, Hwei Ling Tan, et al.
European Urology|July 15, 2014
A multigene assay identifying distinct prognostic subtypes of clear cell renal cell carcinoma with differential response to tyrosine kinase inhibitionYukti Choudhury, Xiaona Wei, Ying-Hsia Chu, et al.
Leukemia & Lymphoma|June 10, 2022
Clinicopathological factors affecting prognosis in marginal zone lymphoma in Asian patients: a cohort studyYao Hao Teo, Yao Neng Teo, Lay Poh Khoo, et al.
The Journal of Trauma and Acute Care Surgery|June 14, 2023
Longitudinal study evaluating post-ICU syndrome differences between acute care surgery and trauma SICU survivorsSamantha F Bottom-Tanzer, Janelle O Poyant, Maria T Louzada, et al.
Pharmacotherapy|February 6, 2021
Clinical and economic evaluation of a surveillance protocol to manage hepatitis B virus (HBV) reactivation among lymphoma patients with resolved HBV infection receiving rituximabChia Jie Tan, Rajneesh Kumar, Narendran Koomanan, et al.
Pageof 3